Ashok Mishra

Title: Ashok Mishra: Innovator in Biopharmaceuticals

Introduction

Ashok Mishra is a prominent inventor based in Pune, India. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of processes for protein purification and refolding. With a total of 2 patents to his name, his work has the potential to impact the production of therapeutic proteins.

Latest Patents

One of Ashok Mishra's latest patents is titled "Refolding process for antibody's fragments." This invention discloses a method for refolding Ranibizumab, where a solubilized solution of heavy and/or light chains is treated with a refolding buffer under specific conditions. These conditions include pH, temperature, and incubation period, with pH and temperature shifts performed at suitable intervals to achieve high-quality and quantity of refolded protein.

Another significant patent is the "Process for the purification of TNFR:Fc fusion protein." This invention focuses on the purification of TNFR:Fc fusion protein, specifically reducing host cell proteins (HCP). The process utilizes mixed-mode chromatography and/or affinity chromatography to produce TNFR:Fc fusion protein that is substantially free of at least one protein-degrading enzyme present in HCP.

Career Highlights

Ashok Mishra is currently associated with Lupin, Inc., a leading global pharmaceutical company. His work at Lupin has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in biopharmaceutical manufacturing.

Collaborations

Throughout his career, Ashok has collaborated with notable colleagues, including Rustom Sorab Mody and Abir Banerjee. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Ashok Mishra's contributions to the field of biopharmaceuticals through his patents and work at Lupin, Inc. highlight his role as an innovator in the industry. His advancements in protein purification and refolding processes are poised to enhance the production of therapeutic proteins, showcasing the importance of innovation in healthcare.